Primary systemic amyloidosis with ischemic stroke as a presenting complication

Neurology

Volumn 69, Issue 11, 2007, Pages 1136-1141

  Zubkov, Alexander Y ^a   Rabinstein, Alejandro A ^a   Dispenzieri, Angela ^b   Wijdicks, Eelco F M ^a  

^a MAYO CLINIC   (United States)

^b Division of Laboratory Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYLOIDOSIS; ARTICLE; BRAIN EMBOLISM; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL TIME; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE;

ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34948814520     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000276951.39112.2b     Document Type: Article

References (31)

1. Gertz MA, Rajkumar SV. Primary systemic amyloidosis. Curr Treat Options Oncol 2002;3:261-271.
2. Gertz MA, Lacy MQ, Dispenzieri A. Amyloidosis: recognition, confirmation, prognosis, and therapy. Mayo Clin Proc 1999;74:490-494.
3. Rice GP, Ebers GC, Newland F, Wysocki GP. Recurrent cerebral embolism in cardiac amyloidosis. Neurology 1981;31:904-907.
4. Hausfater P, Costedoat-Chalumeau N, Amoura Z, et al. AL cardiac amyloidosis and arterial thromboembolic events. Scand J Rheumatol 2005;34:315-319.
5. Halligan CS, Lacy MQ, Vincent Rajkumar S, et al. Natural history of thromboembolism in AL amyloidosis. Amyloid 2006;13:31-36.
6. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
7. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995;32:45-59.
8. Skinner M, Anderson J, Simms R, et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 1996;100:290-298.
9. Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 1997;336:1202-1207.
10. Kyle RA, Gertz MA, Greipp PR, et al. Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood 1999;93:1062-1066.
11. Goodman HJ, Gillmore JD, Lachmann HJ, Wechalekar AD, Bradwell AR, Hawkins PN. Outcome of autologous stem cell transplantation for AL amyloidosis in the UK. Br J Haematol 2006;134:417-425.
12. Roberts WC, Waller BF. Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol 1983;52:137-146.
13. Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation 2005;112:2047-2060.
14. Klein AL, Hatle LK, Taliercio CP, et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1990;16:1135-1141.
15. Koyama J, Davidoff R, Falk RH. Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr 2004;17:36-44.
16. Koyama J, Ray-Sequin PA, Davidoff R, Falk RH. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol 2002;89:1067-1071.
17. Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 2003;107:2446-2452.
18. Cueto-Garcia L, Tajik AJ, Kyle RA, et al. Serial echocardiographic observations in patients with primary systemic amyloidosis: an introduction to the concept of early (asymptomatic) amyloid infiltration of the heart. Mayo Clin Proc 1984;59:589-597.
19. Palladini G, Malamani G, Co F, et al. Holter monitoring in AL amyloidosis: prognostic implications. Pacing Clin Electrophysiol 2001;24 (pt 1):1228-1233.
20. Falk RH, Rubinow A, Cohen AS. Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities. J Am Coll Cardiol 1984;3:107-113.
21. Chamarthi B, Dubrey SW, Cha K, Skinner M, Falk RH. Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol 1997;80:1242-1245.
22. Rocken C, Peters B, Juenemann G, et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation 2002;106:2091-2097.
23. Palacio S, Hart RG. Neurologic manifestations of cardiogenic embolism: an update. Neurol Clin 2002;20:179-193, vii.
24. Hart RG. Atrial fibrillation and stroke prevention. N Engl J Med 2003;349:1015-1016.
25. Rodgers H, Greenaway J, Davies T, Wood R, Steen N, Thomson R. Risk factors for first-ever stroke in older people in the north East of England: a population-based study. Stroke 2004;35:7-11.
26. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 1987;147:1561-1564.
27. Cabin HS, Clubb KS, Hall C, Perlmutter RA, Feinstein AR. Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol 1990;65:1112-1116.
28. Yamanouchi H, Mizutani T, Matsushita S, Esaki Y. Paroxysmal atrial fibrillation: high frequency of embolic brain infarction in elderly autopsy patients. Neurology 1997;49:1691-1694.
29. Rem JA, Hachinski VC, Boughner DR, Barnett HJ. Value of cardiac monitoring and echocardiography in TIA and stroke patients. Stroke 1985;16:950-956.
30. Barthelemy J-C, Feasson-Gerard S, Garnier P, et al. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann Noninvasive Electrocardiol 2003;8:194-199.
31. Jung DK, Devuyst G, Maeder P, Bogousslavsky J. Atrial fibrillation with small subcortical infarcts. J Neurol Neurosurg Psychiatry 2001;70:344-349.